A business in context
EWTX research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-08-13 | Donovan Joanne M. | S · Sale | Common Stock | 2919.0 | 43.41 |
| 2026-08-12 | Russell Alan J | A · Grant / award | Stock Option (Right to Buy) | 65000.0 | 0.0 |
| 2026-08-12 | Russell Alan J | S · Sale | Common Stock | 3238.0 | 43.68 |
| 2026-08-12 | Russell Alan J | M · Exercise / conversion | Common Stock | 7031.0 | 0.0 |
| 2026-08-12 | Russell Alan J | M · Exercise / conversion | Common Stock | 5781.0 | 0.0 |
| 2026-08-12 | Russell Alan J | S · Sale | Common Stock | 390.0 | 44.46 |
| 2026-08-12 | Russell Alan J | S · Sale | Common Stock | 2273.0 | 43.68 |
| 2026-08-12 | Russell Alan J | M · Exercise / conversion | Restricted Stock Units | 5781.0 | 0.0 |
| 2026-08-12 | Russell Alan J | M · Exercise / conversion | Restricted Stock Units | 7031.0 | 0.0 |
| 2026-08-12 | Russell Alan J | A · Grant / award | Restricted Stock Units | 32500.0 | 0.0 |
| 2026-08-12 | Russell Alan J | A · Grant / award | Stock Option (Right to Buy) | 65000.0 | 0.0 |
| 2026-08-12 | Derakhshan Behrad | A · Grant / award | Stock Option (Right to Buy) | 100000.0 | 0.0 |
| 2026-08-12 | Derakhshan Behrad | S · Sale | Common Stock | 150.0 | 44.44 |
| 2026-08-12 | Derakhshan Behrad | S · Sale | Common Stock | 2475.0 | 43.7 |
| 2026-08-12 | Derakhshan Behrad | S · Sale | Common Stock | 304.0 | 44.5 |
| 2026-08-12 | Derakhshan Behrad | S · Sale | Common Stock | 2171.0 | 43.79 |
| 2026-08-12 | Derakhshan Behrad | M · Exercise / conversion | Common Stock | 7500.0 | 0.0 |
| 2026-08-12 | Derakhshan Behrad | M · Exercise / conversion | Common Stock | 5781.0 | 0.0 |
| 2026-08-12 | Derakhshan Behrad | A · Grant / award | Restricted Stock Units | 50000.0 | 0.0 |
| 2026-08-12 | Derakhshan Behrad | M · Exercise / conversion | Restricted Stock Units | 7500.0 | 0.0 |
| 2026-08-12 | Derakhshan Behrad | M · Exercise / conversion | Restricted Stock Units | 5781.0 | 0.0 |
| 2026-08-12 | Derakhshan Behrad | A · Grant / award | Stock Option (Right to Buy) | 100000.0 | 0.0 |
| 2026-08-12 | Nofi Michael | A · Grant / award | Stock Option (Right to Buy) | 48750.0 | 0.0 |
| 2026-08-12 | Nofi Michael | A · Grant / award | Stock Option (Right to Buy) | 48750.0 | 0.0 |
| 2026-08-12 | Nofi Michael | A · Grant / award | Restricted Stock Units | 24375.0 | 0.0 |
| 2026-08-12 | Donovan Joanne M. | A · Grant / award | Stock Option (Right to Buy) | 65000.0 | 0.0 |
| 2026-08-12 | Donovan Joanne M. | S · Sale | Common Stock | 800.0 | 44.52 |
| 2026-08-12 | Donovan Joanne M. | S · Sale | Common Stock | 104.0 | 44.43 |
| 2026-08-12 | Donovan Joanne M. | S · Sale | Common Stock | 2779.0 | 43.71 |
| 2026-08-12 | Donovan Joanne M. | S · Sale | Common Stock | 2839.0 | 43.78 |
| 2026-08-12 | Donovan Joanne M. | M · Exercise / conversion | Common Stock | 7031.0 | 0.0 |
| 2026-08-12 | Donovan Joanne M. | M · Exercise / conversion | Common Stock | 5781.0 | 0.0 |
| 2026-08-12 | Donovan Joanne M. | A · Grant / award | Restricted Stock Units | 32500.0 | 0.0 |
| 2026-08-12 | Donovan Joanne M. | A · Grant / award | Stock Option (Right to Buy) | 65000.0 | 0.0 |
| 2026-08-12 | Donovan Joanne M. | M · Exercise / conversion | Restricted Stock Units | 5781.0 | 0.0 |
| 2026-08-12 | Donovan Joanne M. | M · Exercise / conversion | Restricted Stock Units | 7031.0 | 0.0 |
| 2026-08-12 | MOORE JOHN R | A · Grant / award | Stock Option (Right to Buy) | 65000.0 | 0.0 |
| 2026-08-12 | MOORE JOHN R | S · Sale | Common Stock | 2439.0 | 43.81 |
| 2026-08-12 | MOORE JOHN R | M · Exercise / conversion | Common Stock | 6718.0 | 0.0 |
| 2026-08-12 | MOORE JOHN R | S · Sale | Common Stock | 59.0 | 44.41 |
| 2026-08-12 | MOORE JOHN R | S · Sale | Common Stock | 99.0 | 44.5 |
| 2026-08-12 | MOORE JOHN R | S · Sale | Common Stock | 2419.0 | 43.8 |
| 2026-08-12 | MOORE JOHN R | M · Exercise / conversion | Common Stock | 5781.0 | 0.0 |
| 2026-08-12 | MOORE JOHN R | A · Grant / award | Stock Option (Right to Buy) | 65000.0 | 0.0 |
| 2026-08-12 | MOORE JOHN R | M · Exercise / conversion | Restricted Stock Units | 6718.0 | 0.0 |
| 2026-08-12 | MOORE JOHN R | M · Exercise / conversion | Restricted Stock Units | 5781.0 | 0.0 |
| 2026-08-12 | MOORE JOHN R | A · Grant / award | Restricted Stock Units | 32500.0 | 0.0 |
| 2026-08-12 | KOCH KEVIN | S · Sale | Common Stock | 8276.0 | 43.66 |
| 2026-08-12 | KOCH KEVIN | S · Sale | Common Stock | 8782.0 | 43.64 |
| 2026-08-12 | KOCH KEVIN | M · Exercise / conversion | Common Stock | 21875.0 | 0.0 |
Identity & relationships
SEC issuer · 0001710072Edgewise Therapeutics, Inc.
Search names and former names
Revenue in constant purchasing power
No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.
Explore the CPI history ↗